Vnus To Double Closure Sales Force Following $57.5 Mil. IPO
This article was originally published in The Gray Sheet
Executive Summary
Vnus Medical Technologies intends to spend at least $8 mil. of the proceeds from a proposed $57.5 mil. initial public offering on sales, marketing and reimbursement activities, the company disclosed in an Aug. 18 prospectus outlining the deal.